Treating cancer with Hsp90 inhibitory compounds

• 收藏
• 分享

专利权人:

Synta Pharmaceuticals Corp.

发明人:

Acquaviva, Jaime,He, Suqin,Proia, David

申请号：

AU2013259267

公开号：

AU2013259267A1

申请日:

2013.05.10

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

A method for treating cancer with a mutation in ROS or RET, comprising identifying a subject with a cancer with a mutation in ROS or RET, and administering to the subject an effective amount of a compound according to formulae (I) OR (la) or a tautomer, or a pharmaceutically acceptable salt thereof, wherein the variables structural formulae are defined herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/